Tizanidine

Related products

• 

  Familial spastic paraplegia

  Botulinum toxin

  【Product name】XEOMIN

  [English common name]incobotulinumtoxinA

  [Chinese common name]Botulinum toxin

  [English name]BTX, Botulinum Toxin

  [Chinese other name]Net good, angel bot

  [Indications] Eyelids, hemifacial spasms and related disorders of dystonia.

  [Usage and Dosage] The recommended dose of this product should not be interchanged with the dose of other Clostridium botulinum toxin preparations. This product must be used by a physician with appropriate qualifications and experience in treatment, and with appropriate equipment. The optimal effective dose and the optimal number of injection sites per muscle have not yet been established, so individual treatment regimens should be developed by the physician and the optimal dose should be determined by titration. Ailigen will assist in the training of this product injection technology. The recommended dose range for each injection site is 0.05-0.1 ml (eyelid, hemifacial spasm). See the following dilution table. Injection of this product with a sterile, 27-30/0.40-0.30mm needle does not necessarily require EMG monitoring. The recommended initial injection dose for the lateral part of the medial and lateral parts of the upper orbital iliac muscle of the upper eyelid iliac muscle is 1.25-2.5 U. If the eyebrows, the lateral aspect of the orbicularis and the upper facial area affect visual acuity, the injection site should also be increased at the corresponding site. Avoiding injections close to the upper eyelid side can reduce complications of drooping eyelids. Avoid the injection of the inside of the lower eyelid to reduce the spread of the oblique muscle, which can reduce the complications of double vision. The lower icon shows the injection reference site: it takes effect within three days after the general injection and reaches a peak in 1-2 weeks. Each treatment lasts for approximately 3 months and can be repeated as needed. When repeating treatment, if the initial therapeutic dose is considered insufficient, the injected dose can be increased or even doubled. However, if an injection site dose exceeds 5.0 U, there will be no better effect. The initial therapeutic dose per eye should not exceed 25U. In general, treatment frequencies greater than once every 3 months are not beneficial to the patient. When treating eyelids, the total dose per 12 weeks should not exceed 100U. Hemifacial spasm and VII pairs of patients with abnormal brain function, treatment of patients with unilateral orbital, and other affected facial muscles can be injected as needed. If the first treatment fails, ie one month after the injection, there is no significant clinical improvement compared to before treatment, the following measures should be taken: • Clinical validation, including specialists performing an EMG examination of the blockade of injected muscle; • Analysis failure Causes such as: improper selection of injected muscles, insufficient injection dose, lack of injection technique, occurrence of fixed muscle contracture, antagonism of muscle weakness, neutralization of toxin antibody formation, etc.; • Re-evaluation of treatment with Clostridium botulinum toxin type A; • If the first treatment is not effective, the following measures can be taken for the second treatment:
  (1) Analyze the cause of the first treatment failure and adjust the dose;
  (2) Injection under EMG monitoring;
  (3) There is a three-month interval between the two treatments. If the reinjection treatment fails or is not effective, consider replacing the treatment. How to use, handle and dispose of this product: It is recommended to carry out the dilution operation and the preparation of the syringe on the paper towel with plastic liner to prevent the liquid from splashing. The product was diluted with sterile, preservative-free saline (0.9% sodium chloride for injection). Draw the appropriate amount of diluent with a syringe (see the dilution table below). Since the product will be denatured by the vibration of bubbles or similar forces, the diluent should be gently pushed into the bottle. If there is no vacuum suction in the bottle, the bottle should be discarded. After preparation, this product should be a clear liquid with no color to slightly yellow and no impurities. Before using the preparation solution, visually check the clarity and impurities. The preparation solution should be stored in the refrigerator (2 ° C - 8 ° C) for up to 4 hours. This product can only be used in a single use, and the remaining solution should be discarded. For safety reasons, unused vials should be filled with a small amount of water and then autoclaved; all used vials, syringes, and spilled liquids should be autoclaved or 0.5% hypochlorous acid. The salt solution inactivated the residue of the product for 5 minutes.

  [Storage] Store at 2oC~8oC in cold storage or below -5oC. After preparation: Store at 2oC~8oC in cold storage and use within 4 hours. Container: A 10 ml capacity type I colorless glass bottle with a rubber stopper and sealed with aluminum foil.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Familial spastic paraplegia

  Tolterodine

  【Product name】Stock

  [English common name]Tolterodine

  [Chinese common name]Tolterodine

  [English name]

  [Chinese other name]

  [indications]
  Tolterodine tartrate tablets: This product is suitable forExcessive bladderExcitation caused by frequent urination, urgency or urgent urinary incontinence symptoms.
  Tolterodine Tartrate Capsule: This product is suitable for the treatment of urinary frequency, urgency or urgent urinary incontinence caused by excessive bladder excitement.
  Tolterodine tartrate sustained release capsule: This product is suitable for the treatment of urinary frequency, urgency or urgent urinary incontinence caused by excessive bladder excitement.

  【Dosage】
  Tolterodine tartrate tablets: The initial recommended dose is 1 tablet at a time, 2 times a day. Depending on the patient's response and tolerance, the dose can be adjusted down to one and a half tablets, twice a day. For patients with hepatic insufficiency or who are taking CYP3A4 inhibitors (see [Drug Interactions]), the recommended dose is one and a half tablets, twice a day.
  Tolterodine Tartrate Capsules: The maximum dose to volunteers is a single dose of 12.8 mg of tolterodine L-tartrate. The most serious adverse reaction is dysregulation and dysuria. In this event of excessive product, gastric lavage and activated carbon are used for treatment.
  Tolterodine tartrate sustained-release capsules: The initial recommended dose is 2 mg each time, twice daily. Depending on the patient's response and tolerance, the dose can be adjusted down to 1 mg each time, twice daily. For patients with hepatic insufficiency or who are taking CYP3A4 inhibitors (see drug interactions), the recommended dose is 1 mg each time, twice daily.

  [Storage]
  Tolterodine tartrate tablets: sealed, stored at room temperature (10 ~ 30 ° C).
  Tolterodine tartrate capsule: shading, confined preservation.
  Tolterodine tartrate sustained release capsule: 15-30 ° C protected from light.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Familial spastic paraplegia

  Oxibutin

  【Product name】Oxytrol, DITROPAN

  [English common name]Oxybutynin

  [Chinese common name]Oxibutin

  [English name]Oxibutynin

  [Chinese other name]Hydroxybutynin

  [indications]
  Oxybutynin hydrochloride sustained-release capsule: antispasmodic drug. For the treatment of acute (tight) forced urinary incontinence, urgency, frequent urination and other symptomsOveractive bladder(OAB) is also indicated for the treatment of neurogenic detrusor hyperactivity (eg caused by spina bifida) in children 6 years of age and older.
  Oxybutynin hydrochloride oral solution: for the relief of symptoms associated with urination in patients with non-inhibitory and reflux neurogenic bladder dysfunction, such as urgency, frequent urination, urinary incontinence, nocturia and enuresis.
  Oxybutynin hydrochloride sustained-release tablets: antispasmodic drugs. It is used to treat overactive bladder (OAB) with symptoms such as acute (tight) urge incontinence, urgency, and frequent urination.
  Oxybutynin hydrochloride capsule: This product is an antispasmodic drug for patients with non-inhibitory and reflux neurogenic bladder dysfunction and symptom relief associated with urination, such as urgency, frequent urination, urinary incontinence, nocturia and enuresis Wait.
  Oxybutynin hydrochloride tablets: This product is an antispasmodic drug for patients with non-inhibitory and reflux neurogenic bladder dysfunction and symptom relief associated with urination, such as urgency, frequent urination, urinary incontinence, nocturia and enuresis Wait.

  【Dosage】
  Oxybutynin hydrochloride sustained-release capsules:
  1. Adult: The initial dose is recommended to be 5-10mg once a day, then gradually increase the dose according to the efficacy and tolerance, each time increase 5mg, the maximum dose is 30mg / day, the dose adjustment generally takes about one week interval. Children over 2.6 years old: The initial recommended dose is 5mg once a day, then gradually increase the dose according to the efficacy and tolerance, each time increase 5mg, the maximum dose is 20mg / day. This product needs to be swallowed with liquid and cannot be chewed or crushed.
  Oxybutynin hydrochloride oral solution:
  1. The usual oral dose for adults is 5ml (5mg with oxybutynin hydrochloride), 2 to 3 times a day; the maximum dose is 5ml (5mg with oxybutynin hydrochloride), 4 times a day. Or follow the doctor's advice.
  Oral dosage of children over 2.5 years old, 5ml at a time (5mg with oxybutynin hydrochloride), 2 times a day; maximum dose, 5ml at a time (5mg with oxybutynin hydrochloride), 3 times a day. Or follow the doctor's advice.
  The clinical data of children under 3.5 years of age is insufficient and is not recommended. The cap can be used for measuring cups, each cover to the engraved line 5ml.
  Oxybutynin hydrochloride sustained-release tablets: The initial recommended dose is once a day, 5mg (half tablet), and then gradually increase the dose according to the efficacy and tolerance, each time increase 5mg, the maximum dose is 30mg / day, or as directed Children are reduced. This product needs to be swallowed with liquid, can not be chewed or crushed, but can be taken according to the half line.
  Oxybutynin hydrochloride capsules: The usual dosage for oral administration in adults is 5 mg (1 capsule) once a day, 2 to 3 times a day; the maximum dose is 5 mg (1 capsule) at a time, 4 times a day. Or follow the doctor's advice. Oral dosage of children over 5 years old, 5mg (1 capsule) at a time, 2 times a day; maximum dose, 5mg (1 capsule) at a time, 3 times a day. Or follow the doctor's advice. The clinical data of children under 5 years of age is insufficient and is not recommended.
  Oxybutynin hydrochloride tablets: The usual dosage for oral administration in adults is 5 mg once a day, 2 to 3 times a day; the maximum dose is 5 mg once a day, 4 times a day. Or follow the doctor's advice. Oral dosage of children over 5 years old, 5mg once, 2 times a day; maximum dose, 5mg once, 3 times a day. Or follow the doctor's advice. The clinical data of children under 5 years of age is insufficient and is not recommended.

  [Storage]
  Oxybutynin hydrochloride sustained-release capsule: sealed and placed in a cool place.
  Oxybutynin hydrochloride oral solution: sealed, placed in a cool place.
  Oxybutynin hydrochloride sustained-release tablets: shading, confined preservation.
  Oxybutynin hydrochloride capsules: shading, sealed, kept in a cool dry place.
  Oxybutynin hydrochloride tablets: shading, sealed, kept in a cool dry place.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Familial spastic paraplegia , Spinocerebellar ataxia

  Baclofen

  【Product name】Baclofen tablets

  [English common name]Baclofen

  [Chinese common name]Baclofen

  [English name]

  [Chinese other name]

  [Indications] This product is used to relieve skeletal muscle spasm caused by:
  1. Multiple sclerosis, syringomyelia, spinal cord tumor, transverse myelitis, spinal cord trauma and motor neuron disease.
  2. Cerebrovascular disease, cerebral palsy, meningitis, and craniocerebral trauma.

  [Usage and Dosage] Oral Adult: The recommended initial dose is 5mg, three times a day, the dose should be gradually increased, and 5mg should be taken every 3 days until the required dose, but the dose should be adjusted according to the patient's reaction. The initial dose of patients sensitive to this product should be 5~10mg daily, and the dose should be slow. The usual dose is 30mg to 75mg per day, depending on the condition, up to 100~120mg per day. Children: The daily dose is 0.75~2mg/kg body weight. For children over 10 years of age, the maximum daily dose can reach 2.5mg/kg body weight. Usually 2.5mg each time at the start of treatment, 4 times a day. Carefully increase the dose approximately every 3 days until the individual requirements of the child are reached. The recommended daily maintenance dose is as follows: 12 months to 2 years old children: 10~20mg

  [Storage] Sealed and placed in a cool place. Please keep out of reach of children.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.